NCT01388283
Completed
Not Applicable
Inflammatory Markers in Pregnant Women Destined to Develop Preeclampsia
Oslo University Hospital0 sites129 target enrollmentJanuary 1999
ConditionsPreeclampsia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Preeclampsia
- Sponsor
- Oslo University Hospital
- Enrollment
- 129
- Status
- Completed
- Last Updated
- 14 years ago
Overview
Brief Summary
The purpose of this study is to assess the predictive role of serum inflammatory markers in pregnant women who subsequently develop preeclampsia.
Investigators
Eligibility Criteria
Inclusion Criteria
- •caucasian,
- •nulliparous
Exclusion Criteria
- •preexisting cardiovascular diseases,
- •diabetes,
- •hypertension,
- •inflammatory bowel diseases,
- •serious organ diseases, and
- •development of separate gestational diabetes and/or hypertension.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Effects of Vitamin D Supplementation During Pregnancy on Clinical Outcomes and Immune FunctionVitamin D DeficiencyNCT01417351USDA, Western Human Nutrition Research Center60
Completed
Not Applicable
Inflammatory Markers in PreeclampsiaPreeclampsiaNCT01385813Oslo University Hospital129
Completed
Not Applicable
Inflammatory Biomarkers for the Diagnosis of oPRESPosterior Reversible Encephalopathy SyndromeInflammatory BiomarkersNeutrophil-lymphocyte RatioNCT05433870Dunjin Chen621
Terminated
Not Applicable
Kinetics of Inflammation Markers in Maternal Plasma: Study of the Correlation With the Diagnosis of Chorioamnionitis in Women Hospitalized for Spontaneous Rupture of the Fetal MembranesPatients With Spontaneous Rupture of the Fetal MembranesNCT01903759Centre Hospitalier Universitaire Dijon97
Withdrawn
Phase 1
Inflammatory Response and Pregnancy Outcome in Women With Type 2 Diabetes or OverweightInflammationNCT00311064Rigshospitalet, Denmark280